Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.180
+0.040 (3.52%)
Mar 31, 2025, 3:11 PM EDT - Market open

PACB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
3515392,6241,8504,5134,833
Upgrade
Market Cap Growth
-79.47%-79.47%41.85%-59.02%-6.61%514.40%
Upgrade
Enterprise Value
6359882,7921,9644,3874,667
Upgrade
Last Close Price
1.141.839.818.1820.4625.94
Upgrade
PE Ratio
-----164.37
Upgrade
PS Ratio
2.033.5013.0814.4234.5861.26
Upgrade
PB Ratio
0.661.063.743.295.7114.41
Upgrade
P/TBV Ratio
-----14.41
Upgrade
P/FCF Ratio
----261.74
Upgrade
P/OCF Ratio
----247.80
Upgrade
EV/Sales Ratio
4.136.4213.9315.3033.6159.16
Upgrade
EV/FCF Ratio
----252.78
Upgrade
Debt / Equity Ratio
1.331.331.331.691.210.13
Upgrade
Debt / FCF Ratio
-----2.28
Upgrade
Asset Turnover
0.100.100.110.070.110.28
Upgrade
Inventory Turnover
1.841.842.662.003.683.36
Upgrade
Quick Ratio
6.306.307.033.0014.908.72
Upgrade
Current Ratio
7.487.487.813.2415.369.24
Upgrade
Return on Equity (ROE)
-51.30%-51.30%-48.53%-46.42%-32.17%15.06%
Upgrade
Return on Assets (ROA)
-12.08%-12.08%-11.04%-10.10%-9.20%-23.22%
Upgrade
Return on Capital (ROIC)
-12.91%-12.91%-12.33%-11.70%-10.49%-26.41%
Upgrade
Earnings Yield
-87.79%-57.53%-11.69%-16.99%-4.01%0.61%
Upgrade
FCF Yield
-60.13%-39.41%-10.21%-15.14%-2.60%0.38%
Upgrade
Buyback Yield / Dilution
-8.22%-8.22%-12.95%-10.00%-16.67%-14.71%
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q